JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 8, 2005; DOI: 10.1124/jpet.105.095356


0022-3565/06/3171-11-18$20.00
JPET 317:11-18, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.095356v1
317/1/11    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Y.
Right arrow Articles by Wang, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y.
Right arrow Articles by Wang, M.-H.

CARDIOVASCULAR

Induction of Renal 20-Hydroxyeicosatetraenoic Acid by Clofibrate Attenuates High-Fat Diet-Induced Hypertension in Rats

Yiqiang Zhou, Hui Huang, Hsin-Hsin Chang, Juan Du, Jing Feng Wu, Cong-Yi Wang, and Mong-Heng Wang

Department of Physiology (Y.Z., H.H., H.-H.C., J.D., M.-H.W., J.F.W.) and Center for Biotechnology and Genomic Medicine (C.-Y.W.), Medical College of Georgia, Augusta, Georgia; and Renal Department of the Second Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China (M.-H.W.)

This study compared renal hemodynamics, the expression of CYP4A isoforms [the enzymes for 20-hydroxyeicosatetraenoic acid (20-HETE) production], and tubular sodium transporters in male rats fed a high-fat (HF) or control diet for 10 weeks. We also studied the effect of treatment with clofibrate, a CYP4A inducer, on sodium retention and renal function and on CYP4A expression in HF rats. HF rats had higher blood pressure (BP), renal plasma flow, and glomerular filtration rate (GFR), but no significant change in renal vascular resistance. Reverse transcription-polymerase chain reaction analysis showed that CYP4A1 and CYP4A8 expression was significantly decreased in the renal cortex of HF rats. Western blot analysis showed up-regulation of expression of the {alpha}-subunit of the epithelial sodium channel ({alpha}-ENaC), the beta-subunit of the epithelial sodium channel (beta-ENaC), sodium/hydrogen exchanger (NHE)-3, and the renal outer medulla K+ channel (ROMK) in HF rats, whereas expression of the {gamma}-subunit of the epithelial sodium channel and the {alpha}1-subunit of Na+-K+-ATPase remained unchanged. Thus, HF treatment caused the reduction of renal CYP4A1 and CYP4A8 expression, whereas the increases in {alpha}-ENaC, beta-ENaC, NHE-3, and ROMK expression in renal tubules may have contributed sodium retention and hypertension in HF rats. Furthermore, clofibrate treatment (240 mg/kg/day) caused the decrease of BP and GFR and the attenuation of cumulative sodium balance in HF rats. The attenuation of sodium retention by clofibrate treatment is linked to decreased expression of NHE-3 in renal cortex. Clofibrate induction of CYP4A expression occurred in proximal tubules and in the thick ascending limb of the loop of Henle but not in renal microvessels. This induction correlated with the expression of peroxisome proliferator-activated receptor (PPAR{alpha}) in renal tubules. Therefore, these results suggest that the effects of clofibrate on sodium retention and blood pressure regulation in HF rats may be due to the induction of renal tubular 20-HETE production through the PPAR{alpha} pathway.


Received September 8, 2005; accepted December 5, 2005.

Address correspondence to: Dr. Mong-Heng Wang, Department of Physiology, Medical College of Georgia, Augusta, GA 30912. E-mail: mwang{at}mail.mcg.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Luo, Y. Zhou, H.-H. Chang, J. Zhang, T. Seki, C.-Y. Wang, E. W. Inscho, and M.-H. Wang
Glomerular 20-HETE, EETs, and TGF-{beta}1 in diabetic nephropathy
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F556 - F563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-J. Chen, J. Li, and J. Quilley
Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2305 - H2312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Huang, C. Morisseau, J. Wang, T. Yang, J. R. Falck, B. D. Hammock, and M.-H. Wang
Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F342 - F349.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. E. Stec, R. J. Roman, A. Flasch, and M. J. Rieder
Functional polymorphism in human CYP4F2 decreases 20-HETE production
Physiol Genomics, June 19, 2007; 30(1): 74 - 81.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.